Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the ...

Cayson Acquisition Corp (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The Company’s units will be listed on the Nasdaq Global Market ...

Lucid Capital Markets, LLC is acting as the sole book-running manager for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 900,000 units at the ...

OpenAI faces significant challenges if it pursues an initial public offering in the near future, including rewriting its ...

The German government said an initial public offering would be the preferred option to sell utility Uniper SE.

Ltd achieved substantial success, garnering 30.46 times subscription on its final bidding day. The logistics company's IPO ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

Hamilton, Bermuda, Sept. 19, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon ...

Phoenix Overseas Limited, a company specializing in agricultural commodities and fashion accessories, is set to open its ...

Donald Trump has vowed not to sell his Trump Media shares after a lock-up period expires Thursday. The company's shares are ...

Upstream Bio has filed for an IPO on Nasdaq under the symbol "UPB," following recent biotech listings. The company focuses on ...

BioAge Labs, a clinical-stage biotech firm focused on obesity and metabolic disease therapies, aims to raise up to $157.5 million through its initial public offering and private placement, Bloomberg ...